Rodolphe Barrangou

Rodolphe Barrangou is an Associate Professor of Food Science and the Todd R. Klaenhammer Distinguished Scholar in Probiotics Research at North Carolina State University. His research focuses on CRISPR-Cas9 in bacteria.[1]

Rodolphe Barrangou
Alma mater
Scientific career
Institutions

In 2017, Barrangou was named[2] Editor-in-Chief of The CRISPR Journal, a peer-reviewed journal covering the field of genome editing and CRISPR research, which debuted in February 2018.

He was elected to the National Academy of Sciences in 2018.[3]

Background

Dr Barrangou's research has been funded by the National Institutes of Health, National Science Foundation, US Department of Agriculture, and institutional grants.[4] He previously worked as an Adjunct Professor of Food Science at Pennsylvania State University, and R&D Director of Genomics at DuPont.

In 2007, Barrangou was the first author on a paper published in Science providing experimental proof for the immune function of CRISPR.[5] He has worked with Jennifer Doudna on Cas9 guided RNA characterization. He has been awarded 17 patents as of 2016.[4]

Education

Awards
  • 2018 NAS Prize in Food and Agriculture Sciences
  • 2017 NAS Award in Molecular Biology
  • 2016 Canada Gairdner International Award
  • 2016 Warren Alpert Foundation Prize
  • 2015 Thomson Reuters Highly Cited Researcher (I-2878-2014)
  • 2015 NC State University Faculty Scholar
  • 2014 NC State Alumni Association Outstanding Research Award recipient
  • 2014 Inducted into Phi Tau Sigma, the Honor Society for Food Science
  • 2011 NC State Food Science Outstanding Young Alumni award recipient
  • 2008 Danisco Innovation Award Recipient
  • 2003 National Science Foundation IGERT Fellow
gollark: So if you invest $10000€ and the company implodes, you ONLY lose $10000€.
gollark: No, limited liability means you can't be sued for a company's debts as an investor, or something like that.
gollark: Without limited liability you could lose MORE than the million you put in.
gollark: No, I mean "safe" as in "you can't lose more than that".
gollark: Ħmm.

References
  1. "Rodolphe Barrangou - FBNS". fbns.ncsu.edu.
  2. "Rodolphe Barrangou, PhD, appointed Editor-in-Chief of The CRISPR Journal". http://www.liebertpub.com/global/pressrelease/rodolphe-barrangou-phd-appointed-editor-in-chief-of-the-crispr-journal/2292/. External link in |website= (help)
  3. http://www.nasonline.org, National Academy of Sciences -. "May 1 2018 NAS Election". www.nasonline.org.
  4. https://fbns.ncsu.edu/faculty/CV/Barrangou_CV_2017.pdf
  5. Barrangou, Rodolphe; Fremaux, Christophe; Deveau, Hélène; Richards, Melissa; Boyaval, Patrick; Moineau, Sylvain; Romero, Dennis A.; Horvath, Philippe (2007-03-23). "CRISPR provides acquired resistance against viruses in prokaryotes". Science. 315 (5819): 1709–1712. doi:10.1126/science.1138140. hdl:20.500.11794/38902. ISSN 1095-9203. PMID 17379808.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.